Reovirus μ2 protein modulates host cell alternative splicing by reducing protein levels of U5 snRNP core components. Issue 9 (30th April 2022)

• Record Type: Journal Article
• Authors: Boudreault, Simon; Durand, Mathieu; Martineau, Carole-Anne; Perreault, Jean-Pierre; Lemay, Guy; Bisaillon, Martin
• Is Part Of: Nucleic acids research. Volume 50:Issue 9(2022)
• Page Start: 5263
• Page End: 5281
• Publication Date: 2022-04-30
• Subjects: Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 572.805
• DOI: 10.1093/nar/gkac272
• Languages: English
• ISSNs: 0305-1048

Abstract

Abstract: Mammalian orthoreovirus (MRV) is a double-stranded RNA virus from the Reoviridae family presenting a promising activity as an oncolytic virus. Recent studies have underlined MRV's ability to alter cellular alternative splicing (AS) during infection, with a limited understanding of the mechanisms at play. In this study, we investigated how MRV modulates AS. Using a combination of cell biology and reverse genetics experiments, we demonstrated that the M1 gene segment, encoding the μ2 protein, is the primary determinant of MRV's ability to alter AS, and that the amino acid at position 208 in μ2 is critical to induce these changes. Moreover, we showed that the expression of μ2 by itself is sufficient to trigger AS changes, and its ability to enter the nucleus is not required for all these changes. Moreover, we identified core components of the U5 snRNP (i.e. EFTUD2, PRPF8, and SNRNP200) as interactors of μ2 that are required for MRV modulation of AS. Finally, these U5 snRNP components are reduced at the protein level by both MRV infection and μ2 expression. Our findings identify the reduction of U5 snRNP components levels as a new mechanism by which viruses alter cellular AS. Graphical Abstract: